1. Aimard, G., Girard, P. F., Raveau, J.: “Sclérose en plaques et processus d'auto-immunisation. Traitement par les anti-mitotiques.” Lyon Med. 6, 345 (1966)
2. Brendel, W., Seifert, J., Lob, G.: “Effect of ‘maximum immune suppression’ with thoracic duct drainage, ALG, Azathioprine and Cortisone in some neurological disorders.” Proc. Roy. Soc. Med. 65, 531 (1972)
3. Camenga, D. L., Nathanson, N.: “An immunopathologic component in experimental togavirus encephalitis.” J. Neuropath. & Exper. Neurol. 34, 492 (1975)
4. Castaigne, P., Lhermitte, F., Schuller, E., Rouques, C., Loridan, M.: “Etude électrophorétique des protéines du liquide céphalo-rachidien au cours de la sclérose en plaques: II. Influence des chimiothérapies immunosuppressives.” Rev. Europ. Etudes Clin. & Biol. 16, 703 (1971)
5. Cendrowski, W. S.: “Multiple sclerosis: Pilot therapeutic trial of immunosuppressants.” Arch. Suisses de Neurol., Neurochir. & Psych. 105, 241 (1969)